Percorrer por assunto Spinocerebellar ataxia type 3

Índice: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

ou inserir as letras iniciais:  

Mostrar 1-8 de um total de 8 resultados.
DataTítuloAutor(es)TipoAcesso
3-Fev-2022Aripiprazole offsets mutant ATXN3-induced motor dysfunction by targeting dopamine D2 and serotonin 1A and 2A receptors in C. elegansJalles, Ana; Vieira, Cármen Maria Leal; Pereira-Sousa, Joana, et al.ArtigoAcesso aberto
Set-2009ATX-3, CDC-48 and UBXN-5: a new trimolecular complex in Caenorhabditis elegansRodrigues, Ana João; Carvalho, Andreia Alexandra Neves; Ferro, Anabela, et al.ArtigoAcesso restrito autor
2019From pathogenesis to novel therapeutics for spinocerebellar ataxia Type 3: Evading potholes on the way to translationDa Silva, Jorge Diogo; Castro, Andreia Cristiana Teixeira; Maciel, P.ArtigoAcesso restrito UMinho
12-Mai-2021Insights from Caenorhabditis elegans models into neurogenetic disorders of the motor system: from fundamental to translational researchSilva, Jorge Diogo Cruz Ramos daTese de doutoramentoAcesso embargado (3 Anos)
2015Novel candidate blood-based transcriptional biomarkers of Machado-Joseph diseaseRaposo, Mafalda; Bettencourt, Conceição; Maciel, P., et al.ArtigoAcesso aberto
24-Nov-2021Preclinical assessment of mesenchymal-stem-cell-based therapies in spinocerebellar ataxia type 3Correia, Joana Sofia Silva; Carvalho, Andreia Alexandra Neves; Pinheiro, Bárbara Filipa Mendes, et al.ArtigoAcesso aberto
2019Preclinical Evidence Supporting Early Initiation of Citalopram Treatment in Machado-Joseph DiseaseEsteves, Sofia; Oliveira, Stéphanie Pereira; Silva, Sara Carina Duarte, et al.ArtigoAcesso aberto
2015Serotonergic signalling suppresses ataxin 3 aggregation and neurotoxicity in animal models of Machado-Joseph diseaseCastro, Andreia Cristiana Teixeira; Sousa, Ana Luísa Jales Monteiro; Esteves, Sofia, et al.ArtigoAcesso aberto